CSL.AX
CSL Ltd
Price:  
138.93 
AUD
Volume:  
1,019,222.00
Australia | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CSL.AX Intrinsic Value

-16.00 %
Upside

What is the intrinsic value of CSL.AX?

As of 2026-04-05, the Intrinsic Value of CSL Ltd (CSL.AX) is 116.75 AUD. This CSL.AX valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 138.93 AUD, the upside of CSL Ltd is -16.00%.

The range of the Intrinsic Value is 84.44 - 179.97 AUD

Is CSL.AX undervalued or overvalued?

Based on its market price of 138.93 AUD and our intrinsic valuation, CSL Ltd (CSL.AX) is overvalued by 16.00%.

138.93 AUD
Stock Price
116.75 AUD
Intrinsic Value
Intrinsic Value Details

CSL.AX Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) 84.44 - 179.97 116.75 -16.0%
DCF (Growth 10y) 120.40 - 236.50 159.95 15.1%
DCF (EBITDA 5y) 312.60 - 395.68 359.74 158.9%
DCF (EBITDA 10y) 327.65 - 444.41 389.17 180.1%
Fair Value 32.75 - 32.75 32.75 -76.43%
P/E 111.40 - 195.62 147.91 6.5%
EV/EBITDA 221.47 - 354.86 293.08 111.0%
EPV 60.11 - 84.89 72.50 -47.8%
DDM - Stable 31.13 - 74.12 52.62 -62.1%
DDM - Multi 107.04 - 181.32 133.20 -4.1%

CSL.AX Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 67,425.51
Beta 0.66
Outstanding shares (mil) 485.32
Enterprise Value (mil) 81,920.35
Market risk premium 5.10%
Cost of Equity 9.22%
Cost of Debt 4.36%
WACC 8.10%